Spine Institute of Louisiana, Shreveport, LA 71101, USA.
Spine J. 2010 Dec;10(12):1043-8. doi: 10.1016/j.spinee.2010.08.014. Epub 2010 Sep 24.
Advancements in the philosophy of "motion preservation" have led to the use of total disc arthroplasty (TDA) as an alternative to fusion for degenerative disc disease (DDD) in the cervical spine. A commonly proposed theory is that TDA could reduce the incidence of adjacent segment disease. All the published clinical studies for TDA discuss the "equal efficacy" results of different investigational device exemption (IDE) trials between TDA and anterior cervical discectomy and fusion (ACDF) but have not addressed the issue of adjacent segment disease.
To present the comparison of outcome data with respect to clinical success rates, symptom-free period, and incidence of adjacent segment disease in 93 patients with one- and two-level cervical DDD treated with TDA or ACDF in three different Food and Drug Administration (FDA) investigational trials.
Prospective, randomized, FDA IDE trials.
Ninety-three patients with established symptomatic one-or two-level cervical disc disease who failed to respond to conservative treatment were randomized to receive TDA (59) or ACDF (34) as part of clinical trials involving three different artificial discs at our institution. Subjects were blind to the assigned group until after the surgery.
Visual analog pain score (VAS), Neck Disability Index, and cervical spine radiographs were collected at 6 weeks and at 3, 6, 12, 24, 36, and 48 months after surgery.
Success of the index surgery was assessed based on outcome measures at the seven data points. Success was defined as reduction by more than 30 points in both VAS and Neck Disability Index, absence of neurological deficits, and no further intervention at the index level. Adjacent segment disease was established by radiology, neurophysiology, and subsequent interventions administered to the patients.
At median follow-up of 37 months (range, 24-49 months), 64 (25 ACDF and 39 TDA) patients satisfied the criteria for clinical success. Neck Disability Index was a better predictor of outcome than pain score (p<.05). Sixteen percent of TDA patients and 18% ACDF patients developed adjacent segment degeneration and were treated actively (p=.3). Concurrent lumbar DDD significantly increased the risk of adjacent segment degeneration (p=.01). Age, gender, smoking habits, and number of levels at index surgery had no predictive value.
Total disc arthroplasty is equivalent to ACDF for providing relief from symptoms in the treatment of one- and two-level DDD of cervical spine. The risk of developing adjacent segment degeneration is equivalent after both procedures but is significantly higher in patients with concurrent DDD in lumbar spine.
“运动保留”理念的进步促使全椎间盘置换术(TDA)成为颈椎退行性椎间盘疾病(DDD)融合术的替代方法。一个常见的理论是,TDA 可以降低邻近节段疾病的发生率。所有已发表的 TDA 临床研究都讨论了 TDA 和前路颈椎间盘切除融合术(ACDF)不同试验间设备豁免(IDE)试验的“等效疗效”结果,但并未涉及邻近节段疾病问题。
本研究旨在比较 93 例接受 TDA 或 ACDF 治疗的单节段和双节段颈椎 DDD 患者的临床成功率、无症状期和邻近节段疾病发生率的结果数据,这些患者来自于我们机构的三项不同食品和药物管理局(FDA)IDE 临床试验。
前瞻性、随机、FDA IDE 试验。
93 例患有明确的单节段或双节段颈椎间盘疾病且对保守治疗无反应的患者,随机分为 TDA 组(59 例)或 ACDF 组(34 例),作为我们机构涉及三种不同人工椎间盘的临床试验的一部分。受试者在手术前一直对分配的组别保持盲态。
手术 6 周后,以及术后 3、6、12、24、36 和 48 个月时收集视觉模拟疼痛评分(VAS)、颈部残疾指数和颈椎影像学检查。
基于七个数据点的结果测量评估索引手术的成功。成功定义为 VAS 和颈部残疾指数均降低 30 分以上,无神经功能缺损,且在索引水平无进一步干预。通过影像学、神经生理学和对患者的后续干预来确定邻近节段疾病。
在中位数为 37 个月(范围 24-49 个月)的随访中,64 例(25 例 ACDF 和 39 例 TDA)患者符合临床成功标准。颈部残疾指数比疼痛评分更能预测结果(p<.05)。16%的 TDA 患者和 18%的 ACDF 患者发生邻近节段退变,并进行了积极治疗(p=.3)。同时患有腰椎 DDD 显著增加了邻近节段退变的风险(p=.01)。年龄、性别、吸烟习惯和指数手术中的节段数均无预测价值。
TDA 与 ACDF 治疗颈椎单节段和双节段 DDD 缓解症状的效果相当。两种手术方法的邻近节段退变风险相当,但同时患有腰椎 DDD 的患者风险显著增加。